{"id":"https://openalex.org/W2132652745","doi":"https://doi.org/10.1096/fj.07-8386com","title":"Prevention and restoration of lactacystin\u2010induced nigrostriatal dopamine neuron degeneration by novel brain\u2010permeable iron chelators","display_name":"Prevention and restoration of lactacystin\u2010induced nigrostriatal dopamine neuron degeneration by novel brain\u2010permeable iron chelators","alternate_titles":[],"publication_year":2007,"publication_date":"2007-08-09","ids":{"openalex":"https://openalex.org/W2132652745","doi":"https://doi.org/10.1096/fj.07-8386com","mag":"2132652745","pmid":"https://pubmed.ncbi.nlm.nih.gov/17690154"},"language":"en","primary_location":{"id":"doi:10.1096/fj.07-8386com","doi":"https://doi.org/10.1096/fj.07-8386com","is_oa":false,"landing_page_url":"https://doi.org/10.1096/fj.07-8386com","pdf_url":null,"source":{"id":"https://openalex.org/S25293849","display_name":"The FASEB Journal","issn_l":"0892-6638","issn":["0892-6638","1530-6860"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The FASEB Journal","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2132652745"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103555459","display_name":"Wen Zhu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I157773358","display_name":"Sun Yat-sen University","ror":"https://ror.org/0064kty71","country_code":"CN","type":"education","lineage":["https://openalex.org/I157773358"]},{"id":"https://openalex.org/I181547552","display_name":"Baylor College of Medicine","ror":"https://ror.org/02pttbw34","country_code":"US","type":"education","lineage":["https://openalex.org/I181547552","https://openalex.org/I2801539370"]},{"id":"https://openalex.org/I4210128921","display_name":"The First Affiliated Hospital, Sun Yat-sen University","ror":"https://ror.org/037p24858","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210128921"]}],"countries":["CN","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Wen Zhu","raw_affiliation_strings":["Department of Neurology Baylor College of Medicine Houston Texas USA","Department of Neurology The 1st Affiliated Hospital of Sun Yat\u2010sen University Guangzhou China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology Baylor College of Medicine Houston Texas USA","institution_ids":["https://openalex.org/I181547552"]},{"raw_affiliation_string":"Department of Neurology The 1st Affiliated Hospital of Sun Yat\u2010sen University Guangzhou China","institution_ids":["https://openalex.org/I157773358","https://openalex.org/I4210128921"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101429836","display_name":"Wenjie Xie","orcid":"https://orcid.org/0000-0003-2637-1881","observed_orcids":["https://orcid.org/0000-0003-2637-1881"]},"institutions":[{"id":"https://openalex.org/I181547552","display_name":"Baylor College of Medicine","ror":"https://ror.org/02pttbw34","country_code":"US","type":"education","lineage":["https://openalex.org/I181547552","https://openalex.org/I2801539370"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Wenjie Xie","raw_affiliation_strings":["Department of Neurology Baylor College of Medicine Houston Texas USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology Baylor College of Medicine Houston Texas USA","institution_ids":["https://openalex.org/I181547552"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101829194","display_name":"Tianhong Pan","orcid":"https://orcid.org/0000-0001-6891-2063","observed_orcids":["https://orcid.org/0000-0001-6891-2063"]},"institutions":[{"id":"https://openalex.org/I181547552","display_name":"Baylor College of Medicine","ror":"https://ror.org/02pttbw34","country_code":"US","type":"education","lineage":["https://openalex.org/I181547552","https://openalex.org/I2801539370"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Tianhong Pan","raw_affiliation_strings":["Department of Neurology Baylor College of Medicine Houston Texas USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology Baylor College of Medicine Houston Texas USA","institution_ids":["https://openalex.org/I181547552"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072714534","display_name":"Pingyi Xu","orcid":"https://orcid.org/0000-0001-8716-5892","observed_orcids":["https://orcid.org/0000-0001-8716-5892"]},"institutions":[{"id":"https://openalex.org/I157773358","display_name":"Sun Yat-sen University","ror":"https://ror.org/0064kty71","country_code":"CN","type":"education","lineage":["https://openalex.org/I157773358"]},{"id":"https://openalex.org/I4210128921","display_name":"The First Affiliated Hospital, Sun Yat-sen University","ror":"https://ror.org/037p24858","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210128921"]}],"countries":["CN"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Pingyi Xu","raw_affiliation_strings":["Department of Neurology The 1st Affiliated Hospital of Sun Yat\u2010sen University Guangzhou China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology The 1st Affiliated Hospital of Sun Yat\u2010sen University Guangzhou China","institution_ids":["https://openalex.org/I157773358","https://openalex.org/I4210128921"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109032535","display_name":"Mati Fridkin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I53964585","display_name":"Weizmann Institute of Science","ror":"https://ror.org/0316ej306","country_code":"IL","type":"education","lineage":["https://openalex.org/I53964585"]}],"countries":["IL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mati Fridkin","raw_affiliation_strings":["The Weizmann Institute of Science Department of Chemistry Rehovot Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Weizmann Institute of Science Department of Chemistry Rehovot Israel","institution_ids":["https://openalex.org/I53964585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067755910","display_name":"Hailin Zheng","orcid":"https://orcid.org/0000-0003-0247-1853","observed_orcids":["https://orcid.org/0000-0003-0247-1853"]},"institutions":[{"id":"https://openalex.org/I53964585","display_name":"Weizmann Institute of Science","ror":"https://ror.org/0316ej306","country_code":"IL","type":"education","lineage":["https://openalex.org/I53964585"]}],"countries":["IL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hailin Zheng","raw_affiliation_strings":["The Weizmann Institute of Science Department of Chemistry Rehovot Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Weizmann Institute of Science Department of Chemistry Rehovot Israel","institution_ids":["https://openalex.org/I53964585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068655451","display_name":"Joseph J. Jankovic","orcid":"https://orcid.org/0000-0003-4129-3674","observed_orcids":["https://orcid.org/0000-0003-4129-3674","https://orcid.org/0000-0002-8773-4677"]},"institutions":[{"id":"https://openalex.org/I181547552","display_name":"Baylor College of Medicine","ror":"https://ror.org/02pttbw34","country_code":"US","type":"education","lineage":["https://openalex.org/I181547552","https://openalex.org/I2801539370"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Joseph Jankovic","raw_affiliation_strings":["Department of Neurology Baylor College of Medicine Houston Texas USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology Baylor College of Medicine Houston Texas USA","institution_ids":["https://openalex.org/I181547552"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053858269","display_name":"Moussa B. H. Youdim","orcid":"https://orcid.org/0000-0002-1361-3872","observed_orcids":["https://orcid.org/0000-0002-1361-3872"]},"institutions":[{"id":"https://openalex.org/I174306211","display_name":"Technion \u2013 Israel Institute of Technology","ror":"https://ror.org/03qryx823","country_code":"IL","type":"education","lineage":["https://openalex.org/I174306211"]}],"countries":["IL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Moussa B. H. Youdim","raw_affiliation_strings":["Technion\u2010Rappaport Family Faculty of Medicine Haifa Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Technion\u2010Rappaport Family Faculty of Medicine Haifa Israel","institution_ids":["https://openalex.org/I174306211"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5007172109","display_name":"Weidong Le","orcid":"https://orcid.org/0000-0001-7459-2705","observed_orcids":["https://orcid.org/0000-0001-7459-2705"]},"institutions":[{"id":"https://openalex.org/I181547552","display_name":"Baylor College of Medicine","ror":"https://ror.org/02pttbw34","country_code":"US","type":"education","lineage":["https://openalex.org/I181547552","https://openalex.org/I2801539370"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Weidong Le","raw_affiliation_strings":["Department of Neurology Baylor College of Medicine Houston Texas USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology Baylor College of Medicine Houston Texas USA","institution_ids":["https://openalex.org/I181547552"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3740,"currency":"USD","value_usd":3740},"apc_paid":null,"fwci":8.386,"has_fulltext":false,"cited_by_count":145,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.98178877,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":100},"biblio":{"volume":"21","issue":"14","first_page":"3835","last_page":"3844"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13481","display_name":"Neurological diseases and metabolism","score":0.0017000000225380063,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13991","display_name":"Nuclear Receptors and Signaling","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/parkinson-s-disease","display_name":"Parkinson's disease","score":0.972000002861023},{"id":"https://openalex.org/keywords/lactacystin","display_name":"lactacystin","score":0.777999997138977},{"id":"https://openalex.org/keywords/iron-chelators","display_name":"iron chelators","score":0.7200000286102295},{"id":"https://openalex.org/keywords/m30","display_name":"M30","score":0.9879999756813049},{"id":"https://openalex.org/keywords/substantia-nigra","display_name":"substantia nigra","score":0.8830000162124634},{"id":"https://openalex.org/keywords/dopaminergic-neuron-degeneration","display_name":"dopaminergic neuron loss","score":0.8980000019073486},{"id":"https://openalex.org/keywords/ubiquitin-proteasome-system","display_name":"ubiquitin-proteasome system","score":0.972000002861023},{"id":"https://openalex.org/keywords/iron-accumulation","display_name":"iron accumulation","score":0.7480000257492065},{"id":"https://openalex.org/keywords/microglial-activation","display_name":"microglial activation","score":0.8669999837875366},{"id":"https://openalex.org/keywords/bcl-2","display_name":"Bcl-2","score":0.8859999775886536},{"id":"https://openalex.org/keywords/neuroprotection","display_name":"neuroprotection","score":0.9779999852180481},{"id":"https://openalex.org/keywords/neurorestoration","display_name":"neurorestoration","score":0.9750000238418579},{"id":"https://openalex.org/keywords/rasagiline","display_name":"rasagiline","score":0.8190000057220459},{"id":"https://openalex.org/keywords/proteasome-inhibition","display_name":"proteasome inhibition","score":0.6489999890327454}],"concepts":[{"id":"https://openalex.org/C2776148510","wikidata":"https://www.wikidata.org/wiki/Q6468907","display_name":"Lactacystin","level":4,"score":0.9961237907409668},{"id":"https://openalex.org/C25498285","wikidata":"https://www.wikidata.org/wiki/Q1981368","display_name":"Neuroprotection","level":2,"score":0.8728528022766113},{"id":"https://openalex.org/C2780938664","wikidata":"https://www.wikidata.org/wiki/Q753278","display_name":"Substantia nigra","level":4,"score":0.8033486008644104},{"id":"https://openalex.org/C27740335","wikidata":"https://www.wikidata.org/wiki/Q14878333","display_name":"Proteasome","level":2,"score":0.6170978546142578},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5418385863304138},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.5178382992744446},{"id":"https://openalex.org/C2778367456","wikidata":"https://www.wikidata.org/wiki/Q7251235","display_name":"Proteasome inhibitor","level":3,"score":0.49085837602615356},{"id":"https://openalex.org/C2781249495","wikidata":"https://www.wikidata.org/wiki/Q420685","display_name":"Rasagiline","level":4,"score":0.4867699146270752},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4583240747451782},{"id":"https://openalex.org/C2778794669","wikidata":"https://www.wikidata.org/wiki/Q43054","display_name":"Neuron","level":2,"score":0.43639662861824036},{"id":"https://openalex.org/C2776669363","wikidata":"https://www.wikidata.org/wiki/Q4287680","display_name":"Medial forebrain bundle","level":4,"score":0.427989661693573},{"id":"https://openalex.org/C2779734285","wikidata":"https://www.wikidata.org/wiki/Q11085","display_name":"Parkinson's disease","level":3,"score":0.379415899515152},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3478410243988037},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.2961558699607849},{"id":"https://openalex.org/C137183658","wikidata":"https://www.wikidata.org/wiki/Q461076","display_name":"Dopaminergic","level":3,"score":0.2580217123031616},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.2562297582626343},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.24388521909713745},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2244415283203125},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.21142986416816711},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000111","descriptor_name":"Acetylcysteine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D000111","descriptor_name":"Acetylcysteine","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001812","descriptor_name":"Blood-Brain Barrier","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D004298","descriptor_name":"Dopamine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D006041","descriptor_name":"Goats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006912","descriptor_name":"Hydroxyquinolines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D006912","descriptor_name":"Hydroxyquinolines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007502","descriptor_name":"Iron Chelating Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D007502","descriptor_name":"Iron Chelating Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008810","descriptor_name":"Mice, Inbred C57BL","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009410","descriptor_name":"Nerve Degeneration","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D009410","descriptor_name":"Nerve Degeneration","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D009474","descriptor_name":"Neurons","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D009474","descriptor_name":"Neurons","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D011817","descriptor_name":"Rabbits","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013378","descriptor_name":"Substantia Nigra","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D013378","descriptor_name":"Substantia Nigra","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1096/fj.07-8386com","doi":"https://doi.org/10.1096/fj.07-8386com","is_oa":false,"landing_page_url":"https://doi.org/10.1096/fj.07-8386com","pdf_url":null,"source":{"id":"https://openalex.org/S25293849","display_name":"The FASEB Journal","issn_l":"0892-6638","issn":["0892-6638","1530-6860"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The FASEB Journal","raw_type":"journal-article"},{"id":"pmid:17690154","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17690154","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2959428267","display_name":"NURR1 Gene Mutations in Parkinson's Disease","funder_award_id":"R01NS043567","funder_id":"https://openalex.org/F4320337359","funder_display_name":"National Institute of Neurological Disorders and Stroke"},{"id":"https://openalex.org/G3871779597","display_name":null,"funder_award_id":"2005\u20132007","funder_id":"https://openalex.org/F4320308987","funder_display_name":"American Parkinson Disease Association"}],"funders":[{"id":"https://openalex.org/F4320308987","display_name":"American Parkinson Disease Association","ror":"https://ror.org/04sedwh45"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337359","display_name":"National Institute of Neurological Disorders and Stroke","ror":"https://ror.org/01s5ya894"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":54,"referenced_works":["https://openalex.org/W23618873","https://openalex.org/W1534557128","https://openalex.org/W1538748480","https://openalex.org/W1862214936","https://openalex.org/W1969609724","https://openalex.org/W1975787195","https://openalex.org/W1976438344","https://openalex.org/W1979710386","https://openalex.org/W1980977603","https://openalex.org/W1981331199","https://openalex.org/W1981835221","https://openalex.org/W1982600877","https://openalex.org/W1985842394","https://openalex.org/W1986696867","https://openalex.org/W1990203556","https://openalex.org/W1994761764","https://openalex.org/W1997789657","https://openalex.org/W1998032181","https://openalex.org/W1998639699","https://openalex.org/W2004349171","https://openalex.org/W2007208756","https://openalex.org/W2011230039","https://openalex.org/W2018974184","https://openalex.org/W2021242983","https://openalex.org/W2023031512","https://openalex.org/W2029309071","https://openalex.org/W2032539115","https://openalex.org/W2032797457","https://openalex.org/W2033706591","https://openalex.org/W2038210942","https://openalex.org/W2044031210","https://openalex.org/W2044130121","https://openalex.org/W2044345769","https://openalex.org/W2049800884","https://openalex.org/W2055359939","https://openalex.org/W2072860074","https://openalex.org/W2082238500","https://openalex.org/W2082860227","https://openalex.org/W2083301989","https://openalex.org/W2085291084","https://openalex.org/W2085842761","https://openalex.org/W2087848764","https://openalex.org/W2088385191","https://openalex.org/W2105161286","https://openalex.org/W2113914842","https://openalex.org/W2114925009","https://openalex.org/W2130902407","https://openalex.org/W2133397461","https://openalex.org/W2156177559","https://openalex.org/W2159134373","https://openalex.org/W2314152567","https://openalex.org/W2408369940","https://openalex.org/W4295689620","https://openalex.org/W6673092402"],"related_works":["https://openalex.org/W2032539115","https://openalex.org/W2130312571","https://openalex.org/W2007241672","https://openalex.org/W3007576459","https://openalex.org/W1990464180","https://openalex.org/W2032381724","https://openalex.org/W2212259686","https://openalex.org/W2888249777","https://openalex.org/W2087772361","https://openalex.org/W2048702149"],"abstract_inverted_index":{"Dysfunction":[0],"of":[1,8,19,36,78,91,183],"the":[2,17,34,41,83,113,117,155],"ubiquitin-proteasome":[3],"system":[4],"(UPS)":[5],"and":[6,25,55,66,129,136,146,185],"accumulation":[7],"iron":[9,26,49,144,169],"in":[10,16,60,149],"substantia":[11],"nigra":[12],"(SN)":[13],"are":[14],"implicated":[15],"pathogenesis":[18],"Parkinson's":[20],"disease":[21],"(PD).":[22],"UPS":[23,177],"dysfunction":[24],"misregulation":[27],"may":[28,189],"reinforce":[29],"each":[30],"other's":[31],"contribution":[32],"to":[33,62],"degeneration":[35],"dopamine":[37],"(DA)":[38],"neurons.":[39],"In":[40,151],"present":[42],"study,":[43],"we":[44],"use":[45],"a":[46,96,103,181,192],"new":[47],"brain-permeable":[48,168],"chelator,":[50],"VK-28":[51,92,128,184],"[5-(4-(2-hydroxyethyl)":[52],"piperazin-1-yl":[53],"(methyl)-8-hydroxyquinoline],":[54],"its":[56],"derivative":[57,182],"M30":[58,99,130,153],"[5-(N-methyl-N-propargyaminomethyl)-8-hydroxyquinoline]":[59],"vivo":[61],"test":[63],"their":[64],"neuroprotective":[65,186,194],"neurorestorative":[67],"properties":[68],"against":[69],"proteasome":[70],"inhibitor":[71],"(lactacystin)":[72],"-induced":[73],"nigrostriatal":[74],"degeneration.":[75],"Bilateral":[76],"microinjections":[77],"lactacystin":[79,114,162],"(1.25":[80],"microg/side)":[81],"into":[82],"mouse":[84],"medial":[85],"forebrain":[86],"bundle":[87],"were":[88,119],"performed.":[89],"Administration":[90],"(5":[93,100],"mg/kg,":[94,101],"once":[95,102],"day)":[97,104],"or":[98,111],"was":[105,159],"applied":[106],"intraperitoneally":[107],"7":[108],"days":[109,122],"before":[110],"after":[112,123,161],"microinjection":[115],"until":[116],"mice":[118],"sacrificed":[120],"28":[121],"microinjection.":[124],"We":[125],"found":[126],"that":[127,167],"both":[131],"significantly":[132],"improved":[133],"behavioral":[134],"performances":[135],"attenuated":[137],"lactacystin-induced":[138],"DA":[139,173],"neuron":[140,174],"loss,":[141],"proteasomal":[142],"inhibition,":[143],"accumulation,":[145],"microglial":[147],"activation":[148],"SN.":[150],"addition,":[152],"restored":[154],"Bcl-2":[156],"level,":[157],"which":[158],"suppressed":[160],"injection.":[163],"These":[164],"findings":[165],"suggest":[166],"chelators":[170],"can":[171],"improve":[172],"survival":[175],"under":[176],"impairment.":[178],"Furthermore,":[179],"M30,":[180],"agent":[187],"rasagiline,":[188],"serve":[190],"as":[191],"better":[193],"therapy":[195],"for":[196],"PD.":[197]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2132652745","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":14},{"year":2014,"cited_by_count":8},{"year":2013,"cited_by_count":16},{"year":2012,"cited_by_count":12}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
